Elanco Animal Health Incorporated (ELAN)
After hours:
| Previous close | 13.47 |
| Open | 13.73 |
| Bid | 13.45 x 1800 |
| Ask | 13.46 x 1300 |
| Day's range | 13.41 - 13.75 |
| 52-week range | 7.88 - 16.88 |
| Volume | |
| Avg. volume | 4,157,991 |
| Market cap | 6.685B |
| Beta (5Y monthly) | 1.30 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- PR Newswire
Elanco's 'Parvo is Poop' Campaign Unleashes Awareness and Action on National Parvo Awareness Day
Elanco Animal Health Incorporated (NYSE: ELAN) today unleashed a multi-faceted educational campaign – declaring today as the first-ever National Parvo Awareness Day, aimed at bringing awareness to this devastating and often-fatal puppy disease. As part of this effort, Elanco is releasing Parvo is Poop – an eye-catching campaign highlighting the way the virus spreads, the symptoms and the breakthrough solution to treat canine parvovirus (parvo).
- PR Newswire
Elanco Confirms Date and Conference Call for First Quarter 2024 Financial Results Announcement
Elanco Animal Health Incorporated (NYSE: ELAN) will announce its first quarter 2024 financial results on Wednesday, May 8, 2024. Elanco will also conduct a conference call on that day with the investment community and media to further detail the company's performance.
- PR Newswire
Elanco Appoints Two Animal Health Industry Executives, Kathy Turner and Craig Wallace, to its Board of Directors
Elanco Animal Health Incorporated (NYSE: ELAN) today announced that it has appointed two new independent directors, Kathy Turner and Craig Wallace, to its Board of Directors (the "Board"), effective immediately, expanding the Board to 14 members.
